Most people think of wound care as a simple routine: clean the cut, apply something to it, and wait for it to heal. This approach works for very minor injuries, but it often falls short for anything ...
Advanced therapies in the treatment of complicated diabetic and non-diabetic foot and leg wounds are helping save limbs and improve the quality of life for individuals plagued by wounds that just ...
A Mesa medical manufacturer of wound care products has achieved a milestone in its development of a treatment of leg ulcers that are difficult to heal. BioLab Holdings has started clinical trials for ...
A thermal-imaging tool to screen for chronic wounds could enable nurses to identify these hard-to-heal sores during the first assessment at a person's home. Nearly half a million Australians live with ...
In combined analysis (n = 39), the average wound closure rate was 98%, and all 19 patients previously diagnosed for potential ...
MediWound has commenced a pivotal, multicentre Phase III VALUE trial to assess its bioactive debridement therapy, EscharEx, for treating venous leg ulcers (VLUs). The primary aim of the trial is to ...
Miami, FL / Syndication Cloud / January 23, 2026 / Kure Care a division of Veracor Group LLC Key Takeaways Approximately 6.5 to 6.7 million people in the U.S. are affected by chronic wounds each year, ...
KureCare is expanding its Medicare-covered wound treatment access ahead of January 2026 CMS reimbursement changes. New site-neutral payment models and stricter documentation requirements will reshape ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results